Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Bristol-Myers Squibb Co (BMS) is a specialty biopharmaceutical company that discovers, develops, licenses, manufactures, markets, distributes and sells medicines to patients with serious diseases. Its primary focus is on cancer, cardiovascular, immunology and virology (including hepatitis B, hepatitis C and HIV infection) therapeutic projects. The company offers its products across the world to retail pharmacies, wholesalers, hospitals, medical professionals and government entities. BMS provides its products in the US, Europe, Japan and other countries. The company conducts research to focus on the discovery and development of novel medicines that address serious diseases in areas of significant unmet medical need. BMS is headquartered in New York City, New York, the US.
Bristol-Myers Squibb Co Key Recent Developments
Sep 22,2020: Anokion announces expansion of exclusive collaboration with Bristol Myers Squibb to develop novel treatments for Autoimmune Diseases
Sep 21,2020: Eurofins Discovery in vitro Pharmacology SafetyScreen44 Panels further increase the value of opnMe.com molecules
Sep 10,2020: Bristol Myers Squibb announces quarterly dividend for third quarter 2020
Sep 08,2020: Bristol Myers Squibb Research at ESMO Virtual Congress 2020 highlights significant progress in cancers with high unmet medical need
Aug 25,2020: BMS agrees to acquire biotherapeutics developer Forbius
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
The profile contains critical company information including:
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Bristol-Myers Squibb Co (BMS) is a specialty biopharmaceutical company that discovers, develops, licenses, manufactures, markets, distributes and sells medicines to patients with serious diseases. Its primary focus is on cancer, cardiovascular, immunology and virology (including hepatitis B, hepatitis C and HIV infection) therapeutic projects. The company offers its products across the world to retail pharmacies, wholesalers, hospitals, medical professionals and government entities. BMS provides its products in the US, Europe, Japan and other countries. The company conducts research to focus on the discovery and development of novel medicines that address serious diseases in areas of significant unmet medical need. BMS is headquartered in New York City, New York, the US.
Bristol-Myers Squibb Co Key Recent Developments
Sep 22,2020: Anokion announces expansion of exclusive collaboration with Bristol Myers Squibb to develop novel treatments for Autoimmune Diseases
Sep 21,2020: Eurofins Discovery in vitro Pharmacology SafetyScreen44 Panels further increase the value of opnMe.com molecules
Sep 10,2020: Bristol Myers Squibb announces quarterly dividend for third quarter 2020
Sep 08,2020: Bristol Myers Squibb Research at ESMO Virtual Congress 2020 highlights significant progress in cancers with high unmet medical need
Aug 25,2020: BMS agrees to acquire biotherapeutics developer Forbius
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
TABLE OF CONTENTS
Section 1 - About the Company
Bristol-Myers Squibb Co - Key Facts
Bristol-Myers Squibb Co - Key Employees
Bristol-Myers Squibb Co - Key Employee Biographies
Bristol-Myers Squibb Co - Major Products and Services
Bristol-Myers Squibb Co - History
Bristol-Myers Squibb Co - Company Statement
Bristol-Myers Squibb Co - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 Company Analysis
Company Overview
Bristol-Myers Squibb Co - Business Description
Business Segment: BioPharmaceuticals
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Others
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: United States
Performance
R&D Overview
Bristol-Myers Squibb Co - Corporate Strategy
Bristol-Myers Squibb Co - SWOT Analysis
SWOT Analysis - Overview
Bristol-Myers Squibb Co - Strengths
Bristol-Myers Squibb Co - Weaknesses
Bristol-Myers Squibb Co - Opportunities
Bristol-Myers Squibb Co - Threats
Bristol-Myers Squibb Co - Key Competitors
Section 3 Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 Companys Lifesciences Financial Deals and Alliances
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Bristol-Myers Squibb Co, Recent Deals Summary
Section 5 Companys Recent Developments
Sep 22, 2020: Anokion announces expansion of exclusive collaboration with Bristol Myers Squibb to develop novel treatments for Autoimmune Diseases
Sep 21, 2020: Eurofins Discovery in vitro Pharmacology SafetyScreen44 Panels further increase the value of opnMe.com molecules
Sep 08, 2020: Bristol Myers Squibb Research at ESMO Virtual Congress 2020 highlights significant progress in cancers with high unmet medical need
Aug 25, 2020: BMS agrees to acquire biotherapeutics developer Forbius
Aug 18, 2020: BMS signs $475m licensing deal with Dragonfly Therapeutics
Aug 12, 2020: Bristol Myers Squibb and the Bristol Myers Squibb Foundation commit $300 million to accelerate and expand health equity and diversity and inclusion efforts
Aug 06, 2020: Bristol Myers Squibb reports second quarter 2020 financial results
Aug 04, 2020: Updated Statement: Bristol Myers Squibb on Coronavirus (COVID-19)
Jul 30, 2020: Bristol Myers Squibb Board elects two new independent directors
Jul 21, 2020: New research for immunotherapy combinations with paclitaxel helping in breast cancer fight
Section 6 Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List Of Tables
Bristol-Myers Squibb Co, Key Facts
Bristol-Myers Squibb Co, Key Employees
Bristol-Myers Squibb Co, Key Employee Biographies
Bristol-Myers Squibb Co, Major Products and Services
Bristol-Myers Squibb Co, History
Bristol-Myers Squibb Co, Subsidiaries
Bristol-Myers Squibb Co, Joint Venture
Bristol-Myers Squibb Co, Key Competitors
Bristol-Myers Squibb Co, Ratios based on current share price
Bristol-Myers Squibb Co, Annual Ratios
Bristol-Myers Squibb Co, Annual Ratios (Cont...1)
Bristol-Myers Squibb Co, Annual Ratios (Cont...2)
Bristol-Myers Squibb Co, Interim Ratios
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Bristol-Myers Squibb Co, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List Of Figures
Bristol-Myers Squibb Co, Performance Chart (2015 - 2019)
Bristol-Myers Squibb Co, Ratio Charts
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
RELATED REPORTS
Bristol-Myers Squibb Full Year Operating Financial
Bristol-Myers Squibb 2023 Full Year Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry This report is part of the
View ReportBristol-Myers Squibb 2023 Third Quarter Operating and Financial Review
Bristol-Myers Squibb 2023 Third Quarter Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry This report is part of the
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
